Optimal Timing of Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in High‐Risk Acute Cholecystitis
Asian Journal of Endoscopic Surgery · 2026-01 · 19 (1)
DOI: 10.1111/ases.70219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Endoscopic Surgery, online erschienen am 21.12.2025. Verfasst von Yutaro Nakagawa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Fukuoka Tokushukai Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Cholecystitis, Acute, Cholecystectomy, Laparoscopic, Drainage, Time-to-Treatment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
The Tokyo Guidelines 2018 recommend early laparoscopic cholecystectomy for acute cholecystitis once the diagnosis is made. In surgical high‐risk patients, however, initial management with antibiotics and gallbladder drainage is advised, followed by standby surgery. The optimal timing of standby surgery after percutaneous transhepatic gallbladder drainage remains unclear. This study aimed to evaluate the timing of standby cholecystectomy after gallbladder drainage in surgical high‐risk patients.
Methods
We retrospectively reviewed 97 patients who underwent cholecystectomy after percutaneous transhepatic gallbladder drainage between January 2019 and July 2024 at our hospital. Patients were classified as surgical high‐risk ( n = 56) or low‐risk ( n = 41) according to the Tokyo Guidelines 2018. In the high‐risk group, both the total cohort and a propensity score‐matched cohort ( n = 22) were analyzed, comparing an early group (surgery within 7 days after gallbladder drainage) and a delay group (surgery ≥ 8 days); patients with Grade III acute cholecystitis were excluded before matching. Clinical characteristics and surgical outcomes were compared.
Results
In the total cohort, C‐reactive protein levels at initial presentation were significantly higher in the delay group ( p < 0.05). All patients with Grade III acute cholecystitis ( n = 9) were included in the delay group. In the matched cohort, surgical outcomes did not differ significantly between groups. However, total hospitalization was significantly shorter in the early group ( p < 0.05).
Conclusions
In surgical high‐risk patients, standby surgery within 7 days after percutaneous transhepatic gallbladder drainage may be preferable, as it shortens hospitalization without compromising surgical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Fukuoka Tokushukai Hospital, Fukuoka, Japan.
ORCID-Profile: Yutaro Nakagawa
Zitieren
APA
Nakagawa, Y., Ito, S., Ishii, F., Ureshino, H., Hara, S., Kawabata, K., Kitano, M., Nakahara, K., Yamazaki, R., Hanaoka, K., Hosoda, Y., Nakamura, R., Komiya, K., Maki, K., Morimoto, M., Yoshida, Y., Inada, K., Yanagisawa, J., & Noritomi, T. (2026). Optimal Timing of Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in High‐Risk Acute Cholecystitis. Asian Journal of Endoscopic Surgery, 19(1). https://doi.org/10.1111/ases.70219
Vancouver
Nakagawa Y, Ito S, Ishii F, Ureshino H, Hara S, Kawabata K, et al. Optimal Timing of Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in High‐Risk Acute Cholecystitis. Asian Journal of Endoscopic Surgery. 2026;19(1). doi:10.1111/ases.70219
BibTeX
@article{Nakagawa2026,
author = {Nakagawa, Yutaro and Ito, Shuhei and Ishii, Fuminori and Ureshino, Hiroki and Hara, Sohsuke and Kawabata, Kouta and Kitano, Masato and Nakahara, Kozue and Yamazaki, Ryo and Hanaoka, Katsuzo and Hosoda, Yasuhito and Nakamura, Ren and Komiya, Kazune and Maki, Kenji and Morimoto, Mitsuaki and Yoshida, Yasushi and Inada, Kazuo and Yanagisawa, Jun and Noritomi, Tomoaki},
title = {Optimal Timing of Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in High‐Risk Acute Cholecystitis},
journal = {Asian Journal of Endoscopic Surgery},
year = {2026},
volume = {19},
number = {1},
doi = {10.1111/ases.70219}
}
EUVIMED